Molecular-targeted agents combination therapy for cancer: Developments and potentials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular-targeted agents combination therapy for cancer: Developments and potentials

Published:2013-06-12 Issue:6 Volume:134 Page:1257-1269
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Li Feifei¹²³,Zhao Changqi¹²,Wang Lili³

Affiliation:

1. Key Laboratory of Cell Proliferation and Regulation Biology; Ministry of Education, Beijing Normal University; Beijing China

2. Gene Engineering and Biotechnology Beijing Key Laboratory; Beijing Normal University; Beijing China

3. Institute of Pharmacology and Toxicology; Academy of Military Medical Sciences; Beijing China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference161 articles.

1. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling;Engelman;Science,2007

2. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins;Guix;J Clin Invest,2008

3. Rational targeting of Notch signaling in cancer;Rizzo;Oncogene,2008

4. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity;Klement;J Clin Invest,2000

5. Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL);Reck;Ann Oncol,2010

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases;Frontiers in Pharmacology;2024-07-26

2. Phenolic Contents, Antioxidant Activities, LCMS Profiles of Mespilus germanica Leaf Extract and Effects on mRNA Transcription Levels of Apoptotic, Autophagic, and Necrotic Genes in MCF7 and A549 Cancer Cell Lines;Cell Biochemistry and Biophysics;2024-06-08

3. Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments;Molecular Pharmaceutics;2024-04-25

4. Biosynthesized metallic nanoparticles: A new era in cancer therapy;Archiv der Pharmazie;2024-04-23

5. ZnO Q-Dots Nanoparticles: Intensifying ROS Stress to Improve Anticancer Drug Efficacy;2024-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3